Table 1.

Recipient demographics, indication for transplantation, induction, and maintenance immunosuppression.

	WARF (n=23)	ASA/CLOP (n=32)	CTL (n=197)	p Value
Gender (M: F)	6: 17	21: 12	118: 79	0.01
Mean age (y)	60	62	55	0.01
Kidney disease (%)			0.54
DM	39%	44%	29%
HTN	17%	25%	17%
Glomerulonephritis	13%	13%	14%
PCKD	9%	6%	12%
Other*	22%	12%	28%
Induction Immunosuppression			0.01
Thymoglobulin	70%	72%	88%
Basiliximab	30%	16%	10%
Other	0%	13%	3%
Maintenance Immunosuppression
Tacrolimus	91%	91%	93%	0.94
Cyclosporine	3%	4%	2%
Other**	6%	4%	5%

^*Includes IgA nephritis, lupus nephritis, Alport Syndrome, obstructive uropathy, drug-induced nephritis, cardiorenal syndrome, hepatorenal syndrome;

^**includes belatacept, rapamycin, and solumedrol only.